Region:  
 
      Advanced
Search
 
Bookmark and Share 
  
Find An Educational Offering
Select Search Criteria
Keyword:
Events starting on or after:  mm/dd/yyyy
Events Added:
Region:
Interest Areas (IA): Hold the CTRL key to select or de-select multiple items from adjacent list box

     
Event Type: Hold the CTRL key to select or de-select multiple items from adjacent list box

 
 
  Click here to Expand the Tab 
10013 Evidence-based Medicine & Health Technology Assessment: Moving From Separate Appraisals to Synergistic Communications
 Overview 
 Agenda / Committee 
 Continuing Education 
 Tutorial / Sub-Events 
 Exhibits 
 Travel/Hotel Information 
 Registration Fees 
 Related Offerings 
 Highlights 
Title:
Evidence-based Medicine & Health Technology Assessment: Moving From Separate Appraisals to Synergistic Communications


Date(s) And Time(s):
Mar 23 2010 12:30PM - Mar 24 2010 5:00PM

Location:
Hilton Washington Embassy Row
2015 MASSACHUSETTS AVE NW,
WASHINGTON, DC 20036-1075

Interest Area(s):
Regulatory Affairs,Statistics,Clinical Research,Medical Communications,Medical Writing,Research & Development

Overview:

 Learn how the once distinct roles involved in developing guidance for evidence-based medicine (EBM) and health technology assessment (HTA) are coming together, particularly from a communications and dissemination perspective.

 

SESSION TOPICS

·         Overview of Evidence-Based Medicine (EBM) and Health Technology Assessment (HTA)

·         Evidence Hierarchies and Methodological Best Practices

·         Use of Evidence and HTA in Coverage Decisions

·         Use of Evidence and EBM in Clinical Guidelines Development

·         Expert Panel Discussion on EBM and HTA for Decision-making



Learning Objectives:

At the conclusion of this meeting, participants should be able to:

       • Compare the methods and data sources for evidence generation and evaluation that support EBM and HTA
• Differentiate the processes employed for HTA across public and private payers in the US and other countries
• Describe generation or evaluation of HTAs and the promotion of EBM that is scientifically rigorous and achievable
• Understand the legal implications and market demands surrounding dissemination of evidence-based information to decision-makers and other healthcare individuals



Target Audience:

This program will benefit individuals involved in:

·         Evidence-based medicine and quality health care

·         Research that generates and analyzes evidence for drug approvals and formulary decision-making

·         Making coverage decisions and managing pharmacy spending

·         Pharmaceutical manufacturing that produces evidence for NDAs and formulary dossiers

·         Reviewing evolving data on safety, effectiveness and affordability of health care



Event Code:
10013

Contact Information:

Contact Wendy Moyer at the DIA office in Horsham, PA by telephone +1.215.293.5810,
fax +1.215.442.6199, or email Wendy.Moyer@diahome.org